semaglutide elisa fda cleared ivd approves obesity drug that helped people cut weight 15% FDA Warns on Certain Forms

Semaglutidethe active ingredient in both Wegovy and compounded formulationsactivates GLP-1 receptors that regulate appetite and blood sugar

These products are compounded in accordance with applicable laws and are to be used only as prescribed by a licensed healthcare provider

See my video Why do we get Fat for more details

With the side effects of long term GLP-1 use being unknown, these alternatives could offer a safer way to lose weight

When she went to her annual appointment this year, she and her physician now believe that her side effects were unfortunately exacerbated by acid reflux that was not well controlled

Escalation typically proceeds: 2.5mg weeks 1-4, 5mg weeks 5-8, 7.5mg weeks 9-12, with potential increases to 10mg, 12.5mg, or 15mg